Synergy Chc CORP 8-K filings

Synergy CHC Corp. has received a notice of default on its Term Loan Credit Agreement due to a missed interest payment, triggering accelerated repayment obligations.

Synergy CHC Corp. announced that Costco Wholesale Corporation will discontinue carrying its FOCUSfactor products, a move expected to materially impact the company's business and financial condition.

Synergy CHC Corp. stockholders approved amendments to the 2024 Equity Incentive Plan, increasing share availability and allowing award repricing.

Synergy CHC Corp. received a notice from Nasdaq indicating its common stock has fallen below the $1.00 minimum bid price requirement, triggering a compliance period.

Synergy CHC Corp. reported first quarter 2026 results with a significant increase in functional beverage revenue, though overall revenue declined year-over-year due to a non-recurring license fee and inventory challenges.

Synergy CHC Corp. has entered into a $36 million equity purchase agreement with Hudson Global Ventures, LLC, along with a common stock purchase warrant.

Synergy CHC Corp. has amended its term loan credit agreement, adjusting payment schedules and covenants, and issued a common stock purchase warrant to a lender.

Synergy CHC Corp. announced the termination of a Brand License Agreement with Gravity Pharma General Trading LLC, impacting $2.9 million in previously recognized revenue.

Synergy CHC Corp. announced its third quarter 2025 financial results, marking its eleventh consecutive quarter of profitability with double-digit revenue growth and significant gross margin expansion.

Synergy CHC Corp. appoints Scott Woodburn as Head of Strategic Partnerships and Teresa Thompson to its Board of Directors to drive functional beverage growth.

Synergy CHC Corp. successfully closed its underwritten public offering, raising $4.375 million in gross proceeds to fund working capital and general corporate purposes.

Synergy CHC Corp. announced a nationwide rollout of its FOCUSfactor Focus + Energy beverage line across over 1,600 EG America convenience store locations, starting Q4 2025.

Synergy CHC Corp. announced its tenth consecutive quarter of profitability, driven by revenue growth, improved gross margins, and strategic expansions.

Synergy CHC Corp. announced a significant wave of new retail and distribution partnerships across North America for its FOCUSfactor supplements and functional beverages, including national authorization with Core-Mark and a national launch in Walmart Canada.

Synergy CHC Corp. announced that its stockholders approved significant corporate governance proposals at its 2025 annual meeting, including the authorization of 1,000,000 shares of preferred stock and an increase in the 2024 Equity Incentive Plan to 2,252,102 shares.

Synergy CHC Corp. announced it has satisfied $12.7 million in debt owed to Knight Therapeutics International S.A. through a combination of cash, an early payment discount, and the issuance of a pre-funded common stock purchase warrant.

Synergy CHC Corp. has announced a new $20 million term loan credit agreement with ACP Agency, LLC, aimed at refinancing existing debt and providing capital for strategic growth initiatives.

Synergy CHC Corp. announces a 30% year-over-year increase in earnings per share for Q1 2025, marking its ninth consecutive quarter of profitability, despite a decrease in revenue.

Synergy CHC Corp. announces its Q4 and full-year 2024 financial results, reporting continued profitability and the appointment of Jaime Fickett as permanent CFO.

Synergy CHC Corp. has announced the resignation of its Chief Financial Officer, Stacy Bieber, effective December 6, 2024, and the appointment of Jaime Fickett as Interim CFO.

Synergy CHC Corp. announced its seventh consecutive quarter of profitability, despite a revenue decrease due to a product re-branding, while also highlighting new retail partnerships and debt reduction.